Principal Scientist, Intravitreal Product Development

Merck Merck · Pharma · NJ

Principal Scientist role focused on sterilization science and sterility assurance for parenteral dosage forms (injections, implants, ophthalmic, inhaled products) from preclinical to commercialization within a cGMP-regulated environment. Responsibilities include defining, evaluating, and implementing sterilization strategies, leading cycle development and validation, and providing technical leadership on cross-functional teams. Requires expertise in sterile drug product development, sterilization technologies, and regulatory expectations.

What you'd actually do

  1. Serve as a principal level sterilization scientist, providing technical leadership for sterilization strategy, sterility assurance, and contamination control for sterile drug products, including injectable, ophthalmic, implantable, and inhaled dosage forms
  2. Define, evaluate, and implement sterilization strategies across development stages, including moist heat, vaporized hydrogen peroxide (VHP), alternative low temperature technologies, and aseptic processing when terminal sterilization is not feasible
  3. Provide strategic technical leadership on cross functional program teams, ensuring robust integration of formulation, container/closure systems, device compatibility, sterilization feasibility, and sterility assurance throughout development
  4. Lead or contribute to sterilization, washing, and decontamination cycle development and validation, including:
  5. Work with cross-functional SME’s from devices, packaging, Tech Ops and other functions to lead the Sterilant selection for a given product profile, based on product impact analysis, cycle time, facility fit, long term sustainability and other factors.

Skills

Required

  • Deep expertise in sterile drug product development across preclinical, clinical, and commercial stages, within a cGMP-regulated environment
  • Demonstrated hands-on and strategic experience in sterilization science, including: Sterilization cycle development and validation, Sterility assurance, microbiology, and environmental monitoring, Endotoxin control and contamination control strategies, Decontamination and disinfection processes
  • Strong understanding of sterilization technologies for pharmaceutical products, medical devices, and combination products, including risk-based selection of terminal vs. aseptic approaches
  • Experience applying Quality by Design (QbD) principles and DOE methodologies to formulation, process, and sterilization development
  • Proven experience with process scale-up, validation, and technology transfer, including collaboration with manufacturing sites and equipment vendors
  • Working knowledge of FDA, ICH, and global regulatory expectations related to sterilization, aseptic processing, and CMC
  • Demonstrated scientific leadership, strong communication skills, and a track record of mentoring and developing junior scientists
  • Ability to operate effectively in cross-functional, matrixed teams and drive decisions in complex technical environments

Nice to have

  • Development and Commercialization experience with Intravitreal product development and launch.
  • Direct experience with working with contract sterilization service providers to develop recipe, transfer to manufacturing sites, and oversight of validation activities.
  • Experience with RTU container sterilization challenges, including glass vial decontamination and low-temperature sterilization alternatives
  • Knowledge of sterile equipment and facility design standards, including involvement in capital project teams and familiarity with FAT, SAT, and qualification/validation activities
  • Track record of supporting or influencing global regulatory filings and inspection readiness
  • Experience delivering technical training

What the JD emphasized

  • cGMP-regulated environment
  • sterilization cycle development and validation
  • sterility assurance
  • contamination control strategies
  • sterilization technologies